2007
DOI: 10.1016/j.jneumeth.2007.03.006
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the neuropeptide content of individual rat neurohypophysial terminals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 18 publications
0
15
0
Order By: Relevance
“…P2X7R antagonist AZ10606120 (10 μM) was applied 30 minutes prior to agonist application and maintained for the duration of the experiment. Eluted samples were frozen and stored at −20°C until AVP content could be determined with an AVP ELISA kit (Enzo Life Sciences, Plymouth Meeting, PA), as directed by manufacturer’s instructions (Custer et al, 2007). …”
Section: Methodsmentioning
confidence: 99%
“…P2X7R antagonist AZ10606120 (10 μM) was applied 30 minutes prior to agonist application and maintained for the duration of the experiment. Eluted samples were frozen and stored at −20°C until AVP content could be determined with an AVP ELISA kit (Enzo Life Sciences, Plymouth Meeting, PA), as directed by manufacturer’s instructions (Custer et al, 2007). …”
Section: Methodsmentioning
confidence: 99%
“…It is certain that this preparation contains only nerve terminals with minimal contamination from the other components and numerous studies have confirmed that the physiological functioning of isolated terminals is the same as in the intact NH [29,41–44]. In addition, we can confirm by immunoblotting [42,45], or specific ELISAs [32] after patch-clamp recordings and Ca 2+ measurements, whether the individual terminal is vasopressinergic or oxcytocinergic. Recently, transgenic rats tagged by a visible fluorescent protein have been developed and successfully employed to study the physiology of AVP (enhanced green fluorescent protein), OT (enhanced cyan fluorescent protein) and OT (monomeric red fluorescent protein) in neurons and terminals [24,4751]…”
Section: The Hypothalamic-neurohypophysial Systemmentioning
confidence: 98%
“…The differences in EC 50 , inactivation, and desensitization of the ATP responses in terminals vs. somata of the HNS indicate that different P2X receptors mediate the responses in the two compartments of these CNS neurons. The HNS somata receptor(s) appears to be a P2X2, P2X4, or P2X6 [100] while the HNS terminal receptor(s) appears to be a mixture of P2X2, P2X3, P2X4, and P2X7 receptors localized on AVP terminals [32,99] and probably only P2X7 is on OT terminals ([101]; see Fig. 3B).…”
Section: Purinergic Effectsmentioning
confidence: 99%
See 1 more Smart Citation
“…Indirect ELISA testing was done with the immunogen neurophysin peptide (aa 78–128; manufacturer's information). This antibody was used for immunohistochemical detection of vassopressinergic neurons in the hypothalamus of mice (Russell et al,2003) and for labelling arginine‐vasopressin in isolated neurohypophyseal nerve terminals of the rat (Custer et al,2007).…”
Section: Methodsmentioning
confidence: 99%